Patient perspectives on switching disease-modifying therapies in the NARCOMS registry

INTRODUCTION: The evolving landscape of disease-modifying therapies (DMTs) for multiple sclerosis raises important questions about why patients change DMTs. Physicians and patients could benefit from a better understanding of the reasons for switching therapy. PURPOSE: To investigate the reasons pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Salter, Amber R, Marrie, Ruth Ann, Agashivala, Neetu, Belletti, Daniel A, Kim, Edward, Cutter, Gary R, Cofield, Stacey S, Tyry, Tuula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094626/
https://www.ncbi.nlm.nih.gov/pubmed/25045254
http://dx.doi.org/10.2147/PPA.S49903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094626/
https://www.ncbi.nlm.nih.gov/pubmed/25045254
http://dx.doi.org/10.2147/PPA.S49903

Ejemplares similares